Check out our most popular compounded medications! Get Started
Calcium Phosphate Dibasic 6.66% Oral Suspension is a compounded medication designed to address conditions such as osteoporosis, rickets, hypocalcemia, hypophosphatemia, and hyperphosphatemia. This formulation is prepared at Bayview Pharmacy, ensuring a uniform dispersion of ingredients for effective administration.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Calcium Phosphate Dibasic 6.66% Oral Suspension is a compounded medication designed to treat a variety of health conditions. This formulation combines calcium and phosphate, two essential minerals for the body, in a liquid dosage form. The ingredients are uniformly dispersed throughout a liquid medium, creating a homogeneous mixture for easy administration.
This medication is primarily used to treat conditions such as hypocalcemia, hypophosphatemia, and osteoporosis. It can also be used to address calcium deficiency in patients with chronic kidney disease. The oral suspension form of this medication is particularly beneficial as it can be taken with or without food, as per the instructions of your healthcare provider.
Calcium Phosphate Dibasic 6.66% Oral Suspension is available in various strengths and forms, including tablets, capsules, and oral suspensions. However, the oral suspension form is often preferred due to its ease of administration and absorption.
While this medication is generally well-tolerated, some patients may experience side effects such as nausea, vomiting, constipation, and abdominal pain. If you experience any of these symptoms, it is crucial to contact your healthcare provider immediately.
If you have any questions or concerns about Calcium Phosphate Dibasic 6.66% Oral Suspension, please do not hesitate to contact us at Bayview Pharmacy. Our team of experienced compounding pharmacists is here to provide you with the information and support you need.
Calcium Phosphate Dibasic 6.66% Oral Suspension is a compounded formulation designed for the treatment of various conditions including hypocalcemia, hypophosphatemia, and osteoporosis. This medication may also be prescribed for other conditions as determined by your healthcare provider. The formulation is a liquid dosage form, where the active ingredient is uniformly dispersed throughout a liquid medium, ensuring a homogeneous mixture for administration.
When treating hypocalcemia, it is recommended that Calcium Phosphate Dibasic 6.66% Oral Suspension be taken with meals or snacks to ensure optimal absorption. Similarly, for the treatment of hypophosphatemia, this medication should be taken with food to enhance absorption and minimize the risk of gastrointestinal side effects. For patients with osteoporosis, taking Calcium Phosphate Dibasic 6.66% Oral Suspension with meals or snacks can help ensure adequate absorption and reduce potential gastrointestinal side effects.
It's important to note that Calcium Phosphate Dibasic 6.66% Oral Suspension may interact with other medications. These can include diuretics, antacids, and calcium supplements. Therefore, it is crucial to inform your healthcare provider about all medications you are currently taking. This includes over-the-counter medications, vitamins, and herbal supplements. If you have any concerns or questions about potential interactions, it is recommended to consult with your healthcare provider.
Calcium Phosphate Dibasic 6.66% Oral Suspension is a compounded formulation designed to treat a range of conditions such as hypocalcemia, hypophosphatemia, and osteoporosis. This medication combines calcium and phosphate, two essential minerals required for optimal body function. The oral suspension is administered orally and is rapidly absorbed into the bloodstream, helping to restore the balance of calcium and phosphate in the body, which is crucial for maintaining healthy bones and muscles.
For the treatment of hypocalcemia, this oral suspension is typically taken once daily, usually in the morning. The dosage is determined based on the patient's age, weight, and overall medical condition. It is crucial to adhere to the prescribed dosage regimen provided by your healthcare provider.
In the case of hypophosphatemia, Calcium Phosphate Dibasic 6.66% Oral Suspension is usually taken twice daily, in the morning and evening. Again, the dosage is determined by the patient's age, weight, and overall medical condition. Consistent adherence to the prescribed dosage regimen is essential for optimal treatment outcomes.
For osteoporosis treatment, this oral suspension is typically taken once daily, usually in the morning. The dosage is determined based on the patient's age, weight, and overall medical condition. As with the other conditions, it is crucial to follow the prescribed dosage regimen exactly as directed by your healthcare provider.
While Calcium Phosphate Dibasic 6.66% Oral Suspension is generally well tolerated, some patients may experience side effects such as nausea, vomiting, constipation, or diarrhea. If you experience any of these side effects, it is important to contact your healthcare provider immediately.
If you have any questions or concerns about Calcium Phosphate Dibasic 6.66% Oral Suspension, please do not hesitate to reach out to us at Bayview Pharmacy. We are committed to helping you understand your medication and how it can contribute to your health and wellbeing.
Calcium Phosphate Dibasic 6.66% Oral Suspension is a compounded formulation that serves multiple therapeutic purposes. It is primarily used to treat conditions such as hypoparathyroidism, renal osteodystrophy, and postmenopausal osteoporosis. This formulation is also beneficial for patients with malabsorption syndromes, including Crohn's disease, celiac disease, and cystic fibrosis, as it supplements calcium and phosphorus levels in the body.
Patients with chronic kidney disease can also benefit from this formulation, as it aids in supplementing calcium and phosphorus. It is also used to prevent and treat calcium and phosphorus deficiencies in patients receiving total parenteral nutrition. Furthermore, Calcium Phosphate Dibasic 6.66% Oral Suspension can be used to address calcium and phosphorus deficiencies in patients with chronic liver disease.
If you have any queries regarding the use of this formulation for any of these conditions, please do not hesitate to contact us. We are here to provide you with the necessary information and guidance.
Calcium Phosphate Dibasic 6.66% Oral Suspension is a liquid medication that contains Calcium Phosphate Dibasic as the active ingredient. It is dispersed uniformly throughout a liquid medium to provide a homogeneous mixture for administration.
Calcium Phosphate Dibasic 6.66% Oral Suspension works by supplementing the body with calcium, a mineral that is essential for many bodily functions, including bone formation and maintenance, blood clotting, and muscle contraction.
Calcium Phosphate Dibasic 6.66% Oral Suspension should be taken as directed by your healthcare provider. The dosage will depend on your medical condition and response to treatment.
If you miss a dose, take it as soon as you remember. If it is near the time of the next dose, skip the missed dose and resume your usual dosing schedule. Do not double the dose to catch up.
Side effects may include constipation, bloating, or upset stomach. If any of these effects persist or worsen, tell your doctor or pharmacist promptly.
Calcium Phosphate Dibasic 6.66% Oral Suspension may interact with other medications. Therefore, it is important to tell your healthcare provider about all the products you use, including prescription drugs, nonprescription drugs, and herbal products.
Consult your healthcare provider before using this medication if you are pregnant, planning to become pregnant, or are breastfeeding. Your healthcare provider will be able to advise you on the risks and benefits of using this medication during these periods.
Calcium Phosphate Dibasic 6.66% Oral Suspension can be used in children as directed by a healthcare provider. However, the dosage may need to be adjusted based on the child's age and weight.
Store this medication at room temperature, away from light and moisture. Do not store in the bathroom. Keep all medications away from children and pets.
If someone has overdosed and has serious symptoms such as passing out or trouble breathing, call emergency services immediately. Otherwise, call a poison control center right away.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take orally
